Abstract
“having a multidisciplinary spine oncology program can improve functional outcomes of patients at risk for paralysis from MESCC. Selected patients derive benefit from a combined modality approach which incorporates novel techniques from each discipline.”
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.